Loading…

Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs

Herein, we bridge beta-cell function and morphology in minipigs. We hypothesized that different aspects of beta-cell dysfunction are present in obesity and obesity with reduced beta-cell mass by using pulsatile insulin secretion as an early marker. Measures for beta-cell function (glucose and argini...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology: endocrinology and metabolism 2005-02, Vol.288 (2), p.E412-E421
Main Authors: Larsen, M O, Juhl, C B, Pørksen, N, Gotfredsen, C F, Carr, R D, Ribel, U, Wilken, M, Rolin, B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3
cites cdi_FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3
container_end_page E421
container_issue 2
container_start_page E412
container_title American journal of physiology: endocrinology and metabolism
container_volume 288
creator Larsen, M O
Juhl, C B
Pørksen, N
Gotfredsen, C F
Carr, R D
Ribel, U
Wilken, M
Rolin, B
description Herein, we bridge beta-cell function and morphology in minipigs. We hypothesized that different aspects of beta-cell dysfunction are present in obesity and obesity with reduced beta-cell mass by using pulsatile insulin secretion as an early marker. Measures for beta-cell function (glucose and arginine stimulation plus baseline and glucose-entrained pulsatile insulin secretion) and islet morphology were studied in long-term (19-20 mo) obese (n = 5) and obese beta-cell-reduced [nicotinamide + streptozotocin (STZ), n = 5] minipigs and normal controls, representing different stages in the development toward type 2 diabetes. Acute insulin response (AIR) to glucose and arginine were, surprisingly, normal in obese (0.3 g/kg glucose: AIR = 246 +/- 119 vs. 255 +/- 61 pM in control; 67 mg/kg arginine: AIR = 230 +/- 124 vs. 214 +/- 85 pM in control) but reduced in obese-STZ animals (0.3 g/kg glucose: AIR = 22 +/- 36, P < 0.01; arginine: AIR = 87 +/- 92 pM, P < 0.05 vs. control). Baseline pulsatile insulin secretion was reduced in obese (59 +/- 16 vs. 76 +/- 16% in control, P < 0.05) and more so in obese-STZ animals (43 +/- 13%, P < 0.01), whereas regularity during entrainment was increased in obese animals (approximate entropy: 0.85 +/- 0.14 vs. 1.13 +/- 0.13 in control, P < 0.01). Beta-cell mass (mg/kg body wt) was normal in obese and reduced in obese-STZ animals, with pancreatic fat infiltration in both groups. In conclusion, obesity and insulin resistance are not linked with a general reduction of beta-cell function, but dynamics of insulin secretion are perturbed. The data suggest a sequence in the development of beta-cell dysfunction, with the three groups representing stages in the progression from normal physiology to diabetes, and assessment of pulsatility as the single most sensitive marker of beta-cell dysfunction.
doi_str_mv 10.1152/ajpendo.00352.2004
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1152_ajpendo_00352_2004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15479954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3</originalsourceid><addsrcrecordid>eNpFkEtOwzAQhi0EoqVwARbIB2iKH-MmWUJVClIlNrCOHHtSXCV2FKeLXowLcDHSh2A2M5qZ7198hNxzNuNciUe9bdHbMGNMKjETjMEFGQ8HkXCl1CUZM57LhGeQj8hNjFvGWKpAXJMRV5DmuYIx8c_Y68RgXdNq503vgqfaW-pijT1tQtd-hTps9tR56kPX6HpKQ4kRp8e340jLv4xGx5h0aHcGLV39fPe98xv0tHHetW4Tb8lVpeuId-c-IZ8vy4_Fa7J-X70tntaJkYz3CQDKTFZYgiyhEpW1khsGNksFahhW89Rak0kAmYECqADKoZScs1yjNHJCxCnXdCHGDqui7Vyju33BWXGQV5zlFUd5xUHeAD2coHZXNmj_kbMt-Qta3m7W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs</title><source>American Physiological Society Journals</source><creator>Larsen, M O ; Juhl, C B ; Pørksen, N ; Gotfredsen, C F ; Carr, R D ; Ribel, U ; Wilken, M ; Rolin, B</creator><creatorcontrib>Larsen, M O ; Juhl, C B ; Pørksen, N ; Gotfredsen, C F ; Carr, R D ; Ribel, U ; Wilken, M ; Rolin, B</creatorcontrib><description>Herein, we bridge beta-cell function and morphology in minipigs. We hypothesized that different aspects of beta-cell dysfunction are present in obesity and obesity with reduced beta-cell mass by using pulsatile insulin secretion as an early marker. Measures for beta-cell function (glucose and arginine stimulation plus baseline and glucose-entrained pulsatile insulin secretion) and islet morphology were studied in long-term (19-20 mo) obese (n = 5) and obese beta-cell-reduced [nicotinamide + streptozotocin (STZ), n = 5] minipigs and normal controls, representing different stages in the development toward type 2 diabetes. Acute insulin response (AIR) to glucose and arginine were, surprisingly, normal in obese (0.3 g/kg glucose: AIR = 246 +/- 119 vs. 255 +/- 61 pM in control; 67 mg/kg arginine: AIR = 230 +/- 124 vs. 214 +/- 85 pM in control) but reduced in obese-STZ animals (0.3 g/kg glucose: AIR = 22 +/- 36, P &lt; 0.01; arginine: AIR = 87 +/- 92 pM, P &lt; 0.05 vs. control). Baseline pulsatile insulin secretion was reduced in obese (59 +/- 16 vs. 76 +/- 16% in control, P &lt; 0.05) and more so in obese-STZ animals (43 +/- 13%, P &lt; 0.01), whereas regularity during entrainment was increased in obese animals (approximate entropy: 0.85 +/- 0.14 vs. 1.13 +/- 0.13 in control, P &lt; 0.01). Beta-cell mass (mg/kg body wt) was normal in obese and reduced in obese-STZ animals, with pancreatic fat infiltration in both groups. In conclusion, obesity and insulin resistance are not linked with a general reduction of beta-cell function, but dynamics of insulin secretion are perturbed. The data suggest a sequence in the development of beta-cell dysfunction, with the three groups representing stages in the progression from normal physiology to diabetes, and assessment of pulsatility as the single most sensitive marker of beta-cell dysfunction.</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00352.2004</identifier><identifier>PMID: 15479954</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Blood Glucose - analysis ; Cells, Cultured ; Diabetes Mellitus, Experimental - chemically induced ; Diabetes Mellitus, Experimental - complications ; Diabetes Mellitus, Experimental - metabolism ; Diabetes Mellitus, Experimental - pathology ; Dietary Fats - metabolism ; Insulin - metabolism ; Insulin Secretion ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Islets of Langerhans - pathology ; Male ; Niacinamide ; Obesity - chemically induced ; Obesity - complications ; Obesity - metabolism ; Obesity - pathology ; Reference Values ; Streptozocin ; Swine ; Swine, Miniature</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2005-02, Vol.288 (2), p.E412-E421</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3</citedby><cites>FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15479954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Larsen, M O</creatorcontrib><creatorcontrib>Juhl, C B</creatorcontrib><creatorcontrib>Pørksen, N</creatorcontrib><creatorcontrib>Gotfredsen, C F</creatorcontrib><creatorcontrib>Carr, R D</creatorcontrib><creatorcontrib>Ribel, U</creatorcontrib><creatorcontrib>Wilken, M</creatorcontrib><creatorcontrib>Rolin, B</creatorcontrib><title>Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>Herein, we bridge beta-cell function and morphology in minipigs. We hypothesized that different aspects of beta-cell dysfunction are present in obesity and obesity with reduced beta-cell mass by using pulsatile insulin secretion as an early marker. Measures for beta-cell function (glucose and arginine stimulation plus baseline and glucose-entrained pulsatile insulin secretion) and islet morphology were studied in long-term (19-20 mo) obese (n = 5) and obese beta-cell-reduced [nicotinamide + streptozotocin (STZ), n = 5] minipigs and normal controls, representing different stages in the development toward type 2 diabetes. Acute insulin response (AIR) to glucose and arginine were, surprisingly, normal in obese (0.3 g/kg glucose: AIR = 246 +/- 119 vs. 255 +/- 61 pM in control; 67 mg/kg arginine: AIR = 230 +/- 124 vs. 214 +/- 85 pM in control) but reduced in obese-STZ animals (0.3 g/kg glucose: AIR = 22 +/- 36, P &lt; 0.01; arginine: AIR = 87 +/- 92 pM, P &lt; 0.05 vs. control). Baseline pulsatile insulin secretion was reduced in obese (59 +/- 16 vs. 76 +/- 16% in control, P &lt; 0.05) and more so in obese-STZ animals (43 +/- 13%, P &lt; 0.01), whereas regularity during entrainment was increased in obese animals (approximate entropy: 0.85 +/- 0.14 vs. 1.13 +/- 0.13 in control, P &lt; 0.01). Beta-cell mass (mg/kg body wt) was normal in obese and reduced in obese-STZ animals, with pancreatic fat infiltration in both groups. In conclusion, obesity and insulin resistance are not linked with a general reduction of beta-cell function, but dynamics of insulin secretion are perturbed. The data suggest a sequence in the development of beta-cell dysfunction, with the three groups representing stages in the progression from normal physiology to diabetes, and assessment of pulsatility as the single most sensitive marker of beta-cell dysfunction.</description><subject>Animals</subject><subject>Blood Glucose - analysis</subject><subject>Cells, Cultured</subject><subject>Diabetes Mellitus, Experimental - chemically induced</subject><subject>Diabetes Mellitus, Experimental - complications</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Diabetes Mellitus, Experimental - pathology</subject><subject>Dietary Fats - metabolism</subject><subject>Insulin - metabolism</subject><subject>Insulin Secretion</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - pathology</subject><subject>Male</subject><subject>Niacinamide</subject><subject>Obesity - chemically induced</subject><subject>Obesity - complications</subject><subject>Obesity - metabolism</subject><subject>Obesity - pathology</subject><subject>Reference Values</subject><subject>Streptozocin</subject><subject>Swine</subject><subject>Swine, Miniature</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkEtOwzAQhi0EoqVwARbIB2iKH-MmWUJVClIlNrCOHHtSXCV2FKeLXowLcDHSh2A2M5qZ7198hNxzNuNciUe9bdHbMGNMKjETjMEFGQ8HkXCl1CUZM57LhGeQj8hNjFvGWKpAXJMRV5DmuYIx8c_Y68RgXdNq503vgqfaW-pijT1tQtd-hTps9tR56kPX6HpKQ4kRp8e340jLv4xGx5h0aHcGLV39fPe98xv0tHHetW4Tb8lVpeuId-c-IZ8vy4_Fa7J-X70tntaJkYz3CQDKTFZYgiyhEpW1khsGNksFahhW89Rak0kAmYECqADKoZScs1yjNHJCxCnXdCHGDqui7Vyju33BWXGQV5zlFUd5xUHeAD2coHZXNmj_kbMt-Qta3m7W</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Larsen, M O</creator><creator>Juhl, C B</creator><creator>Pørksen, N</creator><creator>Gotfredsen, C F</creator><creator>Carr, R D</creator><creator>Ribel, U</creator><creator>Wilken, M</creator><creator>Rolin, B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200502</creationdate><title>Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs</title><author>Larsen, M O ; Juhl, C B ; Pørksen, N ; Gotfredsen, C F ; Carr, R D ; Ribel, U ; Wilken, M ; Rolin, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Blood Glucose - analysis</topic><topic>Cells, Cultured</topic><topic>Diabetes Mellitus, Experimental - chemically induced</topic><topic>Diabetes Mellitus, Experimental - complications</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Diabetes Mellitus, Experimental - pathology</topic><topic>Dietary Fats - metabolism</topic><topic>Insulin - metabolism</topic><topic>Insulin Secretion</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - pathology</topic><topic>Male</topic><topic>Niacinamide</topic><topic>Obesity - chemically induced</topic><topic>Obesity - complications</topic><topic>Obesity - metabolism</topic><topic>Obesity - pathology</topic><topic>Reference Values</topic><topic>Streptozocin</topic><topic>Swine</topic><topic>Swine, Miniature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Larsen, M O</creatorcontrib><creatorcontrib>Juhl, C B</creatorcontrib><creatorcontrib>Pørksen, N</creatorcontrib><creatorcontrib>Gotfredsen, C F</creatorcontrib><creatorcontrib>Carr, R D</creatorcontrib><creatorcontrib>Ribel, U</creatorcontrib><creatorcontrib>Wilken, M</creatorcontrib><creatorcontrib>Rolin, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larsen, M O</au><au>Juhl, C B</au><au>Pørksen, N</au><au>Gotfredsen, C F</au><au>Carr, R D</au><au>Ribel, U</au><au>Wilken, M</au><au>Rolin, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2005-02</date><risdate>2005</risdate><volume>288</volume><issue>2</issue><spage>E412</spage><epage>E421</epage><pages>E412-E421</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>Herein, we bridge beta-cell function and morphology in minipigs. We hypothesized that different aspects of beta-cell dysfunction are present in obesity and obesity with reduced beta-cell mass by using pulsatile insulin secretion as an early marker. Measures for beta-cell function (glucose and arginine stimulation plus baseline and glucose-entrained pulsatile insulin secretion) and islet morphology were studied in long-term (19-20 mo) obese (n = 5) and obese beta-cell-reduced [nicotinamide + streptozotocin (STZ), n = 5] minipigs and normal controls, representing different stages in the development toward type 2 diabetes. Acute insulin response (AIR) to glucose and arginine were, surprisingly, normal in obese (0.3 g/kg glucose: AIR = 246 +/- 119 vs. 255 +/- 61 pM in control; 67 mg/kg arginine: AIR = 230 +/- 124 vs. 214 +/- 85 pM in control) but reduced in obese-STZ animals (0.3 g/kg glucose: AIR = 22 +/- 36, P &lt; 0.01; arginine: AIR = 87 +/- 92 pM, P &lt; 0.05 vs. control). Baseline pulsatile insulin secretion was reduced in obese (59 +/- 16 vs. 76 +/- 16% in control, P &lt; 0.05) and more so in obese-STZ animals (43 +/- 13%, P &lt; 0.01), whereas regularity during entrainment was increased in obese animals (approximate entropy: 0.85 +/- 0.14 vs. 1.13 +/- 0.13 in control, P &lt; 0.01). Beta-cell mass (mg/kg body wt) was normal in obese and reduced in obese-STZ animals, with pancreatic fat infiltration in both groups. In conclusion, obesity and insulin resistance are not linked with a general reduction of beta-cell function, but dynamics of insulin secretion are perturbed. The data suggest a sequence in the development of beta-cell dysfunction, with the three groups representing stages in the progression from normal physiology to diabetes, and assessment of pulsatility as the single most sensitive marker of beta-cell dysfunction.</abstract><cop>United States</cop><pmid>15479954</pmid><doi>10.1152/ajpendo.00352.2004</doi></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2005-02, Vol.288 (2), p.E412-E421
issn 0193-1849
1522-1555
language eng
recordid cdi_crossref_primary_10_1152_ajpendo_00352_2004
source American Physiological Society Journals
subjects Animals
Blood Glucose - analysis
Cells, Cultured
Diabetes Mellitus, Experimental - chemically induced
Diabetes Mellitus, Experimental - complications
Diabetes Mellitus, Experimental - metabolism
Diabetes Mellitus, Experimental - pathology
Dietary Fats - metabolism
Insulin - metabolism
Insulin Secretion
Islets of Langerhans - drug effects
Islets of Langerhans - metabolism
Islets of Langerhans - pathology
Male
Niacinamide
Obesity - chemically induced
Obesity - complications
Obesity - metabolism
Obesity - pathology
Reference Values
Streptozocin
Swine
Swine, Miniature
title Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T01%3A45%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beta-cell%20function%20and%20islet%20morphology%20in%20normal,%20obese,%20and%20obese%20beta-cell%20mass-reduced%20G%C3%B6ttingen%20minipigs&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Larsen,%20M%20O&rft.date=2005-02&rft.volume=288&rft.issue=2&rft.spage=E412&rft.epage=E421&rft.pages=E412-E421&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00352.2004&rft_dat=%3Cpubmed_cross%3E15479954%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c301t-44e383feb43b4f2fdd31c04d872ea4b4f67ddc8344384544f44bbbb53609ae3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15479954&rfr_iscdi=true